Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Mass Law Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Mass Law BlogPatent Reexamination Used to Stall Patent Enforcement
By Lee Gesmer
Here a link to an interesting article in the May 5, 2008 issue of Forbes, that highlights the use of anonymous, ex parte requests for reexamination to the Patent Office. The result of a reexamination is to stall enforcement of the patent against possible infringers.
The article highlights the plight of Anthony Brown, a lawyer that purchased the patent for compression of an electronic file for transmission over a communications line (think JPEG). After Brown purchased the patent -
“A petition filed in 2000 by parties unknown asked the U.S. Patent & Trademark Office to reexamine whether the processes the patent described were novel enough to deserve a patent. The feds agreed to the review, a common practice if the questions raised seem substantial. The catch is that during the review the holder of the patent can’t demand licensing fees, and the patent’s life doesn’t get extended accordingly. The reexam of the JPEG patent lasted seven years”
After the patent survived that challenge, Brown hit his next roadblock -
“But last year saw yet another anonymous challenge. This one was filed by Chicago patent attorney Vernon Francissen, who declines to identify his client. Francissen suggested the JPEG patent’s current version had slipped through an overburdened system and was being applied too broadly. In March the Patent Office agreed to a second reexam, again putting up a roadblock to Brown’s licensing campaign.”
As a result of the impact of a successful request for rexamination, this has become an almost standard prodedure for defendants in patent litigation.
Full post as published by Mass Law Blog on April 25, 2008 (boomark / email).
Child Support Survival Guide
The Child Support Enforcement System
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

Pfizer's Lipitor '893 Patent Survives Reexamination
Second Viread® Patent Survives Reexamination
In re Swanson: CAFC Allows Reexamination Based on Reference Previously Considered by PTO and Courts
Webinar on recent patent cases
USPTO to Reexamine ExonHit Therapeutics Patent








